Cardiovascular disease and US life expectancy

Although the stalled increase in life expectancy in the United States beginning in 2010 has been attributed to drug overdoses and deaths, analysis of data from the Centers for Disease Control and Prevention and the World Health Organization finds that a stall in declining cardiovascular deaths is a more likely explanation and that the stagnant trend is in contrast to trends in other high-income nations, according to a study.

###

Article #19-20391: “US life expectancy stalls due to cardiovascular disease, not drug deaths,” by Neil Mehta, Leah Abrams, and Mikko Myrskylä.

MEDIA CONTACT: Neil Mehta, University of Michigan, Ann Arbor MI; e-mail:

[email protected]

; Mikko Myrskylä, Max Planck Institute for Demographic Research, Rostock, GERMANY; e-mail:

[email protected]